The clinical course of the proliferative and membranous forms of lupus nephritis.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000974:Antibodies, Antinuclear / Q000032:analysis; D000917:Antibody Formation; D001706:Biopsy; D003937:Diagnosis, Differential; D005260:Female; D005455:Fluorescent Antibody Technique; D006417:Hematuria / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000209:etiology; D007674:Kidney Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D007676:Kidney Failure, Chronic / Q000209:etiology; D007678:Kidney Glomerulus / Q000276:immunology / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000276:immunology / Q000473:pathology; D008297:Male; D008854:Microscopy, Electron; D009404:Nephrotic Syndrome / Q000209:etiology; D011507:Proteinuria / Q000209:etiology; D012217:Rheumatoid Factor / Q000032:analysis
D000305:Adrenal Cortex Hormones; D000974:Antibodies, Antinuclear; D012217:Rheumatoid Factor